MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $813M; returns 1 day -4.0%, 1 week +24.1%, 1 year +25.3%.

MoonLake Immunotherapeutics is a clinical-stage biotechnology company headquartered in Zug, Switzerland, focused on developing therapies for inflammatory skin and joint diseases.

Groups MLTX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• Dermatology
• Rheumatoid Arthritis
• Clinical Stage
• Biologics
• Unmet Medical Needs

MLTX financial model: income statement, cash flow and balance sheet